Teva and Amgen latest to submit trastuzumab biosimilars to US FDA for review
The US FDA has accepted submission of two further Herceptin (trastuzumab) biosimilars: ABP 980 developed by Amgen and Allergan, and Teva and Celltrion’s CT-P6.
Archives for July 31, 2017
Thermo Fisher: Modest Q2 for life sciences due to ‘lumpiness’ of bioproduction
Muted bioproduction technology pegged back an otherwise strong quarter, but Thermo Fisher says it expects growth will pick up again over time.
Biotest relocates Florida plasma center, ups workforce
Biotest Pharmaceuticals Corporation has relocated its Plasma Center in Pembroke Pines, Florida, US.